BioLineRx Ltd. Announces Closing of $15 Million Private Placement to Institutional Investors
2/28/2012 6:53:38 AM
JERUSALEM, Israel--(BUSINESS WIRE)--BioLineRx Ltd. (NASDAQ:BLRX) (TASE:BLRX), announced today that it has closed its previously announced $15 million private placement to healthcare-focused U.S. institutional investors. As a result, the Company sold approximately 5.25 million American Depositary Shares (“ADSs”) at a purchase price of $2.86 per ADS, and warrants to purchase up to 2.6 million additional ADSs at an exercise price of $3.57 per ADS. After fees and estimated offering expenses, the Company received net proceeds of approximately $14.1 million.
comments powered by